Deanna L. Kelly, PharmD, BCPP
MPower Professor of Psychiatry, University of Maryland Strategic Partnership: MPowering the State
Acting Director,
Maryland Psychiatric Research Center
University of Maryland School of Medicine
Baltimore, MD
Dr. Kelly has led and been involved in numerous clinical trials in schizophrenia and has been active in psychopharmacology research for the past 25 years. She has been continuously funded by NIMH, NIDA, and private foundations such as the Stanley Medical Research Institute and the Maryland Innovation Initiative for over 20 years.
Dr. Kelly has coauthored and authored 20 books and book chapters, published 230 peer-reviewed articles, presented over 165 posters and has given over 160 invited lectures. She has coauthored three editions of the book entitled “Pharmacologic Treatment of Schizophrenia.” She also authors the Schizophrenia chapter for “Pharmacotherapy, Principles and Practice.” Among many other activities she is a content expert for the CSS SMI Advisor group, Chair of the State of Maryland Department of Mental Health Institutional Review Board and Chairs the Department of Psychiatry Faculty Mentoring Committee.